La siguiente tabla resume los niveles de dosis clsicos estudiados durante la fase de bsqueda de dosis
In this context, we present and discuss the outcomes of the most recent trials investigating the impact of SGLT2 inhibitors and GLP-1-R agonists on renal and cardiovascular outcomes in patients, both with and without T2DM
Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study
Fibre-rich carbohydrates like lentils, beans, vegetables, and berries can support digestion and stabilize blood sugar levels
With digital health innovations, tools like a GLP-1 app are making it easier for patients to track doses, monitor progress, and stay on top of their therapy
The mitigation is well-established and unglamorous: lift weights, eat enough protein